New Lung Cancer Drug Gives Patients More Time as Survival Results Offer Fresh Hope
A new cancer treatment is offering hope to people facing one of the most aggressive forms of lung cancer. Clinical trial results show that patients receiving the drug lived longer on average than those treated with standard chemotherapy, giving doctors another option for a disease that can be difficult to control. The treatment, called tarlatamab, …